A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis (Q28183038)

From Wikidata
Jump to navigation Jump to search
scientific article (publication date: December 2003)
edit
Language Label Description Also known as
English
A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis
scientific article (publication date: December 2003)

    Statements

    A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    Cynthia Helms
    0 references
    Li Cao
    0 references
    Francesca Chamian
    0 references
    Derek Gordon
    0 references
    Michael Heffernan
    0 references
    Jil A Wright Daw
    0 references
    Jurg Ott
    0 references
    Alan Menter
    0 references
    December 2003
    0 references
    35
    0 references
    4
    0 references
    349-56
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit